Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Station1 is a U.S.-based nonprofit research and education organization that develops and supports a model it calls directional or socially-directed science and technology. Rather than operating as a biotech or pharmaceutical developer, it focuses on interdisciplinary research, curriculum, fellowships, and ecosystem partnerships intended to shape the social and environmental impacts of science and technology. Its work spans areas such as artificial intelligence, materials science, infrastructure, energy, and selected biotechnology- and health-technology-adjacent projects through partner networks. The organization is best known for programs such as the Station1 Frontiers Fellowship and for collaborating with startups, nonprofits, and corporations on research and innovation initiatives. It should not be characterized as a therapeutic product company with a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Station1.